JCXH-213
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JCXH-213, covering 2025-06-03 to 2025-06-03. Get the full timeline:
Most recent: Clinical Trial Update: One Trial to Evaluate the Safety, Tolerability and Efficacy of JCXH-213 in Patients With r/r B-NHL [NA]